1.675
price down icon4.42%   -0.0775
after-market Dopo l'orario di chiusura: 1.70 0.025 +1.49%
loading
Precedente Chiudi:
$1.7525
Aprire:
$1.76
Volume 24 ore:
48,734
Relative Volume:
1.87
Capitalizzazione di mercato:
$10.29M
Reddito:
-
Utile/perdita netta:
$-14.29M
Rapporto P/E:
-0.4198
EPS:
-3.99
Flusso di cassa netto:
$-12.27M
1 W Prestazione:
+2.45%
1M Prestazione:
-2.62%
6M Prestazione:
-50.30%
1 anno Prestazione:
-59.05%
Intervallo 1D:
Value
$1.66
$1.7995
Intervallo di 1 settimana:
Value
$1.48
$1.91
Portata 52W:
Value
$1.412
$5.01

Aprea Therapeutics Inc Stock (APRE) Company Profile

Name
Nome
Aprea Therapeutics Inc
Name
Telefono
215-948-4119
Name
Indirizzo
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Name
Dipendente
8
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-07
Name
Ultimi documenti SEC
Name
APRE's Discussions on Twitter

Confronta APRE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
APRE
Aprea Therapeutics Inc
1.675 10.29M 0 -14.29M -12.27M -3.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-12-28 Downgrade Robert W. Baird Outperform → Neutral
2020-12-16 Iniziato Berenberg Buy
2020-09-29 Ripresa JP Morgan Neutral
2020-06-22 Iniziato H.C. Wainwright Neutral
2020-04-21 Iniziato Robert W. Baird Outperform
2019-10-28 Iniziato JP Morgan Neutral
2019-10-28 Iniziato Morgan Stanley Equal-Weight
2019-10-28 Iniziato RBC Capital Mkts Outperform
Mostra tutto

Aprea Therapeutics Inc Borsa (APRE) Ultime notizie

pulisher
Jun 17, 2025

Chronic Lymphocytic Leukemia Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 17, 2025
pulisher
Jun 12, 2025

CoreWeave Stock Skyrockets 137% In A Month: Hold Or Fold? - Barchart.com

Jun 12, 2025
pulisher
Jun 11, 2025

Block Inc. Has Unusual Put Option ActivityShowing Bullish XYZ Investors - Barchart.com

Jun 11, 2025
pulisher
Jun 11, 2025

Ostara Inc. Launches CG P2X In Western Canada: Phosphorus, Perfected - Barchart.com

Jun 11, 2025
pulisher
Jun 11, 2025

Stocks In Play: WSP Global Inc. - Barchart.com

Jun 11, 2025
pulisher
Jun 10, 2025

Alzheimer’s Disease Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

Polycystic Kidney Disease Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

Dry Eye Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

Supporting 2SLGBTQI+ Communities For A Safer, More Equitable And Inclusive Canada - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

Artios' AACR Data Success: What It Means For Aprea Therapeutics' ATRN-119 Program - Barchart.com

Jun 10, 2025
pulisher
Jun 10, 2025

REKO INTERNATIONAL GROUP INC. TO BUY BACK UP TO 276,066 OF ITS COMMON SHARES - Barchart.com

Jun 10, 2025
pulisher
Jun 09, 2025

Aprea Therapeutics Confirms Directors and Accounting Firm - TipRanks

Jun 09, 2025
pulisher
Jun 06, 2025

Stocks Finish Sharply Higher On A Resilient US Labor Market - Barchart.com

Jun 06, 2025
pulisher
Jun 06, 2025

Compass Refresh, Inc. Launches New Headquarters in Sulphur Springs, TX – Bringing High-Quality Exterior Maintenance Across the Southern Region - Barchart.com

Jun 06, 2025
pulisher
Jun 05, 2025

Aprea Therapeutics Teams Up with MD Anderson for Preclinical HNSCC Research - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Aprea Therapeutics expands cancer drug patent portfolio - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

Stocks In Play: Aimia Inc. - Barchart.com

Jun 04, 2025
pulisher
Jun 04, 2025

ADF GROUP INC. Q1-2026 CONFERENCE CALL INVITATION - Barchart.com

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Takes $43,000 Position in Aprea Therapeutics, Inc. (NASDAQ:APRE) - Defense World

Jun 04, 2025
pulisher
May 27, 2025

Galaxy Digital Inc. Announces Public Offering Of Common Stock - Barchart.com

May 27, 2025
pulisher
May 23, 2025

Vermilion Energy Inc. Advances Strategic Portfolio Repositioning with Agreement to Sell its Saskatchewan Assets and Accelerate Debt Repayment - Barchart.com

May 23, 2025
pulisher
May 22, 2025

Acute Myeloid Leukemia Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight - openPR.com

May 22, 2025
pulisher
May 22, 2025

Ovarian Cancer Drugs Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight - openPR.com

May 22, 2025
pulisher
May 19, 2025

Q2 Earnings Estimate for APRE Issued By Wedbush - Defense World

May 19, 2025
pulisher
May 18, 2025

Eton Pharmaceuticals (NASDAQ:ETON) Earns “Buy” Rating from B. Riley - Defense World

May 18, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Sells 752 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) - Defense World

May 18, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Purchases 993 Shares of CTO Realty Growth, Inc. (NYSE:CTO) - Defense World

May 18, 2025
pulisher
May 18, 2025

InMode Ltd. (NASDAQ:INMD) Shares Sold by The Manufacturers Life Insurance Company - Defense World

May 18, 2025
pulisher
May 18, 2025

What is Wedbush’s Estimate for ORKA FY2029 Earnings? - Defense World

May 18, 2025
pulisher
May 18, 2025

Wedbush Forecasts Lower Earnings for Aprea Therapeutics - Defense World

May 18, 2025
pulisher
May 16, 2025

Petro-Victory Energy Corp. Announces Short Term Loan - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Stocks Close Higher On Optimism Over US Trade Negotiations - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Ontario Lottery And Gaming CorporationMidDay Lottery Winning NumbersMay 16, 2025 - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Becton, Dickinson And Company Stock: Analyst Estimates & Ratings - Barchart.com

May 16, 2025
pulisher
May 16, 2025

CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Strathcona Resources Ltd. Reports First Quarter 2025 Financial and Operating Results, Announces Quarterly Dividend and Investment in MEG Energy Corp. - Barchart.com

May 16, 2025
pulisher
May 16, 2025

Aprea Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 16, 2025
pulisher
May 15, 2025

NoticeGO-TO DEVELOPMENTS HOLDINGS INC., GO-TO SPADINA ADELAIDE SQUARE INC., FURTADO HOLDINGS INC., and OSCAR FURTADO, File No. 2022-8 - Barchart.com

May 15, 2025
pulisher
May 15, 2025

RBC Global Asset Management Inc. Announces RBC ETF Cash Distributions For May 2025 - Barchart.com

May 15, 2025
pulisher
May 14, 2025

Strathcona Resources Ltd. Announces Sale of Montney Business for $2.84 Billion and Acquisition of Hardisty Rail Terminal - Barchart.com

May 14, 2025
pulisher
May 14, 2025

BIG ROCK BREWERY INC. ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS - Barchart.com

May 14, 2025
pulisher
May 14, 2025

Psychemedics Named “Most Innovative Drug Testing Company Of The Year” - Barchart.com

May 14, 2025
pulisher
May 14, 2025

This Under-The-Radar Cancer Biotech Reports 21% Tumor Shrinkage: Analysts See 600%+ Upside - Barchart.com

May 14, 2025
pulisher
May 14, 2025

GFL Environmental Inc. Announces Results From Annual General Meeting Of Shareholders - Barchart.com

May 14, 2025
pulisher
May 14, 2025

Aprea (APRE) Reports Q1 Revenue Drop Amid Clinical Progress | AP - GuruFocus

May 14, 2025
pulisher
May 14, 2025

APRE Reports Decrease in Cash Reserves by End of Q1 2025 | APRE Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics Reports Promising Q1 2025 Results - TipRanks

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics reports Q1 EPS (66c) vs. (67c) last year - TipRanks

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update - The Manila Times

May 14, 2025

Aprea Therapeutics Inc Azioni (APRE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Aprea Therapeutics Inc Azioni (APRE) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Duey Marc
Director
Oct 18 '24
Sale
4.58
6,462
29,583
233,651
Gilad Oren
President/CEO
Oct 23 '24
Buy
3.92
500
1,958
333,395
Duey Marc
Director
Oct 16 '24
Buy
4.39
30,000
131,700
240,113
Gilad Oren
President/CEO
Oct 15 '24
Buy
2.90
250
725
332,895
Duey Marc
Director
Oct 14 '24
Buy
2.58
190
490
210,113
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Oct 11 '24
Buy
2.46
50
123
19,368
Seizinger Bernd R.
Director
Oct 11 '24
Buy
2.68
10,000
26,800
44,730
Gilad Oren
President/CEO
Oct 14 '24
Buy
2.59
1,000
2,590
332,645
Gilad Oren
President/CEO
Oct 10 '24
Buy
2.54
150
381
331,645
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Oct 10 '24
Buy
2.61
450
1,174
19,318
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):